Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / EGRX - Eagle Pharmaceuticals Non-GAAP EPS of $1.26 beats by $0.27 revenue of $66.3M beats by $2.97M

EGRX - Eagle Pharmaceuticals Non-GAAP EPS of $1.26 beats by $0.27 revenue of $66.3M beats by $2.97M

Eagle Pharmaceuticals Inc.

2023-05-09 06:55:18 ET

  • Eagle Pharmaceuticals press release ( NASDAQ: EGRX ): Q1 Non-GAAP EPS of $1.26 beats by $0.27 .
  • Revenue of $66.3M (-42.8% Y/Y) beats by $2.97M .
  • Q1 2023 net sales of PEMFEXY totaled $22.9 million; Eagle estimates that it has an approximate 15% share in commercial (non-340B) pemetrexed market for the second quarter of 2023 to date
  • Company reaffirms full year guidance; adjusted EBITDA of $74.0 - $80.0 million and adjusted non-GAAP earnings per share of $4.20 - $4.53 vs $4.24 consensus

For further details see:

Eagle Pharmaceuticals Non-GAAP EPS of $1.26 beats by $0.27, revenue of $66.3M beats by $2.97M
Stock Information
Company Name: Eagle Pharmaceuticals Inc.
Stock Symbol: EGRX
Market: NASDAQ
Website: eagleus.com
Menu
EGRX EGRX Quote EGRX Short EGRX News EGRX Articles EGRX Message Board
Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...